Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Existing investor Tencent is in talks as part of a round the flying car developer reportedly aims to close at between $400m and $500m.

UVC Partners returned to back Fazua together with the electric bike drive system maker's other existing investors and an EIB-run venture debt provider.

Johannes Gutenberg University of Mainz's cancer therapy developer raised $150m despite reducing the number of shares in the IPO and floating beneath its range.

The Eli Lilly, Pfizer and Sanofi-backed cancer therapy developer raised $150m despite reducing the number of shares in the IPO and floating beneath its range.

Qorvo has purchased a portfolio company, radio frequency technology developer Cavendish Kinetics, which was spun out of Cambridge two decades ago.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

University of Oxford-founded autoimmune disease therapy developer MiroBio has launched with support from OSI and GlaxoSmithKline’s SR One.

University of Oxford-founded autoimmune disease therapy developer MiroBio has launched with support from GlaxoSmithKline subsidiary SR One.

The scooter rental platform has now raised more than $95m altogether, after Axa Germany participated in a series B round that will fund European growth.